Emerald ash borer has been confirmed in three new Minnesota counties that will lead to an expanded quarantine.
During this week’s 2025 MDA Conference, the SAPPHIRE trial presentations ... President and Chief Executive Officer of Scholar Rock. “Progressive muscle weakness robs many people with SMA ...
Scholar Rock (SRRK) announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial will be presented in multiple clinical ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for ...